| For: | Shoji Y, Koyanagi K, Kanamori K, Tajima K, Ogimi M, Ninomiya Y, Yamamoto M, Kazuno A, Nabeshima K, Nishi T, Mori M. Immunotherapy for esophageal cancer: Where are we now and where can we go. World J Gastroenterol 2024; 30(19): 2496-2501 [PMID: 38817664 DOI: 10.3748/wjg.v30.i19.2496] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i19/2496.htm |
| Number | Citing Articles |
| 1 |
Yawei Wang, Ye Hu, Yi Qin, Xiangfeng Jin, Yandong Zhao. Low Serum Interleukin-6 Levels Enhance the Efficacy of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2025; doi: 10.1177/10849785251360550
|
| 2 |
Hong-Wei Gao, Kai-Fu Chang, Xiao-Fan Huang, Peng-Yun Hung, Ming-Chang Hsieh, Nu-Man Tsai. Juniperus indica Bertol Extract Combined with 5-Fluorouracil Synergistically Suppresses the Growth of Esophageal Squamous Cell Carcinoma Cells. Natural Product Communications 2025; 20(2) doi: 10.1177/1934578X251324602
|
| 3 |
Ya-Xuan Niu, Min Hu, Wei-Feng Zhao, Hong-Jie Yang. Expression of stem cell marker musashi-1 and its relationship with survival prognosis in patients with resectable esophageal squamous cell carcinoma. World Journal of Stem Cells 2025; 17(8): 107013 doi: 10.4252/wjsc.v17.i8.107013
|
| 4 |
Atsuto Katano. Palliative external beam radiotherapy for dysphagia management in advanced esophageal cancer: a narrative perspective. Oncologie 2025; 27(3): 439 doi: 10.1515/oncologie-2025-0087
|
| 5 |
Xiaodan Liu, Shengju Ren, Xinyang Li, Xiang Cheng, Yujing Fang, Shuo Zhang, Yidi Zhao, Wang Ma, Tengfei Zhang. Prognostic Value of Inflammatory and Nutritional Markers in Advanced Esophageal Squamous Cell Carcinoma Treated with Immunotherapy: A Retrospective Cohort Study. Journal of Inflammation Research 2025; : 15393 doi: 10.2147/JIR.S547500
|
| 6 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 7 |
Amany I. Almars, Sameerah Shaheen, Nahlah M. Ghouth, Iman S. Abumansour, Asim Abdulaziz Khogeer, Fayez Alsulaimani, Ahmed M. Basri, Nasser A. Elhawary, Tabinda Hasan, Hailah M. Almohaimeed. Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology. Clinical and Translational Oncology 2025; doi: 10.1007/s12094-025-04051-4
|
| 8 |
Sung Eun Kim, Kyoungwon Jung, Moo In Park. Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma. Journal of Digestive Cancer Research 2024; 12(2): 72 doi: 10.52927/jdcr.2024.12.2.72
|
| 9 |
Qin Wang, Qing-Rong Li, Lei Xu, Zi-Chun Yuan, Xiao Liu, Mao-Ju Tang, Man Luo, Xiao-Wu Zhong, Qiang Ma, Xiao-Lan Guo. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World Journal of Gastrointestinal Oncology 2025; 17(1): 99376 doi: 10.4251/wjgo.v17.i1.99376
|
| 10 |
Seungbyn Baek, Junha Cha, Min Hee Hong, Gamin Kim, Yoon Woo Koh, Dahee Kim, Wonrak Son, Chan‐Young Ock, Seungeun Lee, Martin Hemberg, Seong Yong Park, Hye Ryun Kim, Insuk Lee. Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses. Cancer Communications 2025; 45(9): 1194 doi: 10.1002/cac2.70046
|
| 11 |
Grigorios Christodoulidis, Sara Eirini Agko, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou, Dimitris Zacharoulis. Advancements and challenges in the treatment of esophageal cancer: A comprehensive review. World Journal of Clinical Oncology 2024; 15(12): 1463-1467 doi: 10.5306/wjco.v15.i12.1463
|
| 12 |
Yoshiaki Shoji, Kohei Kanamori, Kazuo Koyanagi, Tetsuya Otsuka, Rie Nakashima, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Takayuki Nishi, Masaki Mori. Conversion surgery for esophageal and esophagogastric junction cancer. International Journal of Clinical Oncology 2024; 29(12): 1777 doi: 10.1007/s10147-024-02639-4
|
| 13 |
Shilong Wu, Chenyang Xu, Huafeng Liu. Case report: Toxic epidermal necrolysis induced by tislelizumab in a patient with esophageal squamous cell carcinoma. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1522525
|
| 14 |
Huilai Lv, Bisong Chen, Chunyue Gai, Yu Liu, Weilu Ding, Mingbo Wang, Kangbo Sun, Fan Zhang, Yonggang Zhu, Zhenhua Li, Ziqiang Tian. Strategies of neoadjuvant therapy in esophageal cancer: a study on the effects of treatment frequency and surgery interval. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1642765
|
| 15 |
Zijian Qiu, Mixue Sun, Chunyan Dai, Xiaoping Zhu. Immunotherapy-associated autoimmune hemolytic anemia induced by anti-PD-1 therapy in esophageal cancer: A case report and literature review. Medicine 2025; 104(15): e42174 doi: 10.1097/MD.0000000000042174
|
| 16 |
Qiang Zhao, Liang Wang, Xun Yang, Jifeng Feng, Qixun Chen. Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1617681
|
| 17 |
Xihao Xie, Hai Zhang, Haiquan He, Bomeng Wu, Ying Chen, Wanli Lin, Qingyi Feng, Qunqing Chen. Postoperative adjuvant immunotherapy for pathological stage II–IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1517001
|
| 18 |
Jian Gao, Qiming Wang, Fangqiu Fu, Yue Zhao, Teng Yang, Xiangze Li, Yihua Sun, Hong Hu, Longfei Ma, Longsheng Miao, Xiaoyang Luo, Ting Ye, Yiliang Zhang, Yang Zhang, Ziling Huang, Hang Li, Longlong Shao, Midie Xu, Kuaile Zhao, Shiyue Zhang, Mou Zhang, Jun Wang, Chong Dai, Xiaoxiao Shang, Tingyi An, Yawei Zhang, Jiaqing Xiang, Zhiwei Cao, Bin Li, Haiquan Chen. Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02306-8
|
| 19 |
Yingjie Sun, Yuheng Tang, Qi Qi, Jianyu Pang, Yongzhi Chen, Hui Wang, Jiaxiang Liang, Wenru Tang. 101 Machine Learning Algorithms for Mining Esophageal Squamous Cell Carcinoma Neoantigen Prognostic Models in Single-Cell Data. International Journal of Molecular Sciences 2025; 26(7): 3373 doi: 10.3390/ijms26073373
|
| 20 |
Yaru Wang, Qibing Wu. Development and Validation of an Interpretable ML Model for Survival Prediction in Unresectable ESCC with Immunochemotherapy. Cancer Management and Research 2025; : 2609 doi: 10.2147/CMAR.S532944
|
| 21 |
Hossein Taghizadeh, Harun Fajkovic. Immunotherapy in the Management of Penile Cancer—A Systematic Review. Cancers 2025; 17(5): 883 doi: 10.3390/cancers17050883
|
| 22 |
Jian-Zhou Tian, Li Zhang, Fu-Yong Lin, Ren-Jiao He, Wen-Rong Tian, Liu Yan, Guo-Xin Huang, Jin-Wei Ai, Bin Pei, De-Sheng Li. The efficacy and safety of PD-1 inhibitors combined with chemotherapy treatment for advanced esophageal cancer: a network meta-analysis. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1515263
|
| 23 |
Wei Wei, Xiao-Lei Zhang, Hong-Zhen Wang, Lin-Lin Wang, Jing-Li Wen, Xin Han, Qian Liu. Application of deep learning models in the pathological classification and staging of esophageal cancer: A focus on Wave-Vision Transformer. World Journal of Gastroenterology 2025; 31(19): 104897 doi: 10.3748/wjg.v31.i19.104897
Abstract(306) |
Core Tip(280) |
Full Article(HTML)(1324)
|
Full Article with Cover (PDF)-7051K(128)
|
Audio-1470K(9)
|
Peer-Review Report-270K(63)
|
Answering Reviewers-154K(67)
|
Supplementary Material-1014K(57)
|
Full Article (PDF)-6735K(110)
|
Full Article (XML)-165K(60)
|
Times Cited (1)
|
Total Visits (4548)
|
Open
|
